Skip to content

Study of Mindfulness-Based Cognitive Therapy

Toward Identifying the Mechanisms of Action in Mindfulness-Based Cognitive Therapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00943033
Acronym
MBCT
Enrollment
48
Registered
2009-07-21
Start date
2009-08-31
Completion date
2010-07-31
Last updated
2012-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Keywords

MBCT, Mindfulness-Based Cognitive Therapy, Mindfulness, Meditation, Relapse Prevention, Recurrent Depression, Depression, Major Depressive Disorder

Brief summary

Research aimed at assessing changes in depressogenic thinking and the ability to disengage from depressogenic thinking following Mindfulness-Based Cognitive Therapy

Interventions

BEHAVIORALMindfulness-Based Cognitive Therapy

Mindfulness-Based Cognitive Therapy for the prevention of depressive relapse/recurrence

Sponsors

Binghamton University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* History of two or more Major Depressive Episodes or history of a Major Depressive Episode lasting at least one year * Can speak, read, and understand English

Exclusion criteria

* Meet Criteria for Current Major Depressive Episode or are in partial remission * BDI-II score above 19 * Abuse alcohol or drugs * Current Dysthymic Disorder * History of: psychosis when not depressed or intoxicated, Mania, Hypomania, Obsessive Compulsive Disorder, Posttraumatic Stress Disorder, Anorexia Nervosa, Bulimia Nervosa

Design outcomes

Primary

MeasureTime frame
Sustained Attention to Response Taskzero to four weeks pre-treatment and zero to three weeks post-treatment

Secondary

MeasureTime frame
Five Facet Mindfulness Questionnairezero to four weeks pre-treatment and zero to three weeks post-treatment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026